Toll-like receptor 4 signaling is involved in PACAP-induced neuroprotection in BV2 microglial cells under OGD/reoxygenation

References

• Deng YY, Lu J, Ling EA, Kaur C. Role of microglia in the process of inflammation in the hypoxic developing brain. Front Biosci (Schol Ed). 2011;3:884–900.
   PubMedGoogle Scholar
• Kim SU, de Vellis J. Microglia in health and disease. J Neurosci Res. 2005;81(3):302–13.
   PubMed Web of Science ®Google Scholar
• Arimura A. Perspectives on pituitary adenylate cyclase-activating polypeptide (PACAP) in the neuroendocrine, endocrine, and nervous systems. Jpn J Physiol. 1998;48:301–31.
   PubMedGoogle Scholar
• Vaudry D, Gonzalez BJ, Basille M, Yon L, Fournier A, Vaudry H. Pituitary adenylate cyclase activating polypeptide and its receptors: from structure to functions. Pharmacol Rev. 2000;52:269–324.
   PubMed Web of Science ®Google Scholar
• Lenti L, Zimmermann A, Kisa D, Oláh O, Tóth GK, Hegyi O, et al.. PACAP and VIP differentially preserve neurovascular reactivity after global cerebral ischemia in newborn pigs. Brain Res. 2009;1283:50–7.
   PubMed Web of Science ®Google Scholar
• Stetler RA, Gao Y, Zukin RS, Vosler PS, Zhang L, Zhang F, et al.. Apurinic/apyrimidinic endonuclease APE1 is required for PACAP-induced neuroprotection against global cerebral ischemia. Proc Natl Acad Sci USA. 2010;107(7):3204–9.
   PubMed Web of Science ®Google Scholar
• Dejda A, Seaborn T, Bourgault S, Touzani O, Fournier A, Vaudry H, et al.. PACAP and a novel stable analog protect rat brain from ischemia: insight into the mechanisms of action. Peptides. 2011;32:1207–16.
   PubMed Web of Science ®Google Scholar
• Reglodi D, Tamás A, Somogyvári-Vigh A, Szántó Z, Kertes E, Lénárd L, et al.. Effects of pretreatment with PACAP on the infarct size and functional outcome in rat permanent focal cerebral ischemia. Peptides. 2002;23:2227–34.
   PubMed Web of Science ®Google Scholar
• Reglodi D, Kiss P, Lubics A, Tamas A. Review on the protective effects of PACAP in models of neurodegenerative diseases in vitro and in vivo. Curr Pharm Des. 2011;17(10):962–72.
   PubMed Web of Science ®Google Scholar
• Vaudry D, Gonzalez BJ, Basille M, Pamantung TF, Fontaine M, Fournier A, et al.. The neuroprotective effect of pituitary adenylate cyclase activating polypeptide on cerebellar granule cells is mediated through inhibition of the CED3-related cysteine protease caspase-3/CPP32. Proc Natl Acad Sci USA. 2000;97:13390–5.
   PubMed Web of Science ®Google Scholar
• Vaudry D, Rousselle C, Basille M, Falluel-Morel A, Pamantung TF, Fontaine M, et al.. Pituitary adenylate cyclase-activating polypeptide protects rat cerebellar granule neurons against ethanol-induced apoptotic cell death. Proc Natl Acad Sci USA. 2002;99:6398–403.
   PubMed Web of Science ®Google Scholar
• Dejda A, Nowak JZ. Neuroprotective potential of three neuropeptides PACAP, VIP and PHI. Pharmocol Reports. 2005;57:307–20.
   PubMed Web of Science ®Google Scholar
• Suk Kyoungho, Park JH, Lee WH. Neuropeptide PACAP inhibits hypoxic activation of brain microglia: a protective mechanism against microglial neurotoxicity in ischemia. Brain Res. 2004;1026:151–6.
   PubMed Web of Science ®Google Scholar
• Serebrovskaya TV, Nikolsky IS, Nikolska VV, Mallet RT, Ishchuk VA. Intermittent hypoxia mobilizes hematopoietic progenitors and augments cellular and humoral elements of innate immunity in adult men. High Alt Med Biol. 2011;12(3):243–52.
   PubMed Web of Science ®Google Scholar
• Wang X, Stridh L, Li W, Dean J, Elmgren A, Gan L, et al.. Lipopolysaccharide sensitizes neonatal hypoxic-ischemic brain injury in a MyD88-dependent manner. J Immunol. 2009;183(11);7471–7.
   PubMed Web of Science ®Google Scholar
• Brusselle GG, Joos GF, Bracke KR. New insights into the immunology of chronic obstructive pulmonary disease. Lancet. 2011;378(9795):1015–26.
   PubMed Web of Science ®Google Scholar
• Beutler B. Inferences, questions and possibilities in Toll-like receptor signaling. Nature. 2004;430:257–63.
   PubMed Web of Science ®Google Scholar
• Rakoff-Nahoum S, Medzhitov R. Role of Toll-like receptors in tissue repair and tumorigenesis. Biochemistry (Mosc). 2008;73:555–61.
   PubMed Web of Science ®Google Scholar
• Cao Z, Hu Y, Wu W, Ha T, Kelley J, Deng C, et al.. The TIR/BB-loop mimetic AS-1 protects the myocardium from ischaemia/reperfusion injury. Cardiovasc Res. 2009;84(3):442–51.
   PubMed Web of Science ®Google Scholar
• Takeda K, Akira S. Toll-like receptors in innate immunity. Int Immunol. 2005;17(1):1–14.
   PubMed Web of Science ®Google Scholar
• Chearwae W, Bright JJ. 15-deoxy-delta(12,14)-prostaglandin J(2) and curcumin modulate the expression of Toll-like receptors 4 and 9 in autoimmune T lymphocyte. J Clin Immunol. 2008;28:558–70.
   PubMed Web of Science ®Google Scholar
• O’Neill LA, Bryant CE, Doyle SL. Therapeutic targeting of toll-like receptors for infectious and inflammatory diseases and cancer. Pharmacol Rev. 2009;61:177–97.
   PubMed Web of Science ®Google Scholar
• Velayudham A, Hritz I, Dolganiue A, Mandrekar P, Kurt-Jones E, Szabo G. Critial role of Toll- like receptors and the common TLR adaptor, MyD88, in induction of granulomas and liver injury. J Hepatol. 2006;45(6):813–24.
   PubMed Web of Science ®Google Scholar
• Yang YX, Zhou HD, Yang YB, Li W, Zhou M, Zeng Z, et al.. Lipopolysaeeharide (LPS) regulates TLR4 signal transduction in nasopharynx epithelial cell line 5-8F via NF-kappaB and MAPKS signaling pathways. Mol Immunol. 2007;44(5):984–92.
   PubMed Web of Science ®Google Scholar
• Zwagerman N, Plumlee C, Guthikonda M, Ding Y. Toll-like receptor-4 and cytokine cascade in stroke after exercise. Neurol Res. 2010;32(2):123–6.
   PubMed Web of Science ®Google Scholar
• Wang ZF, Zhou J, Tang XC. Huperzine B protects rat pheochromocytoma cells against oxygen-glucose deprivation-induced injury. Acta Pharmacol Sin. 2002;23(12):1193–8.
   PubMed Web of Science ®Google Scholar
• Zhu SM, Xiong XX, Zheng YY, Pan CF. Propofol inhibits aquaporin 4 expression through a protein kinase C-dependent pathway in an astrocyte model of cerebral ischemia/reoxygenation. Anesth Analg. 2009;109(5):1493–9.
   PubMed Web of Science ®Google Scholar
• Bourgault S, Vaudry D, Dejda A, Doan ND, Vaudry H, Fournier A. Pituitary adenylate cyclase-activating polypeptide: focus on structure-activity relationships of a neuroprotective peptide. Curr Med Chem. 2009;16(33):4462–80.
   PubMed Web of Science ®Google Scholar
• Zhu L, Tamvakopoulos C, Xie D, Dragovic J, Shen X, Fenyk-Melody JE, et al.. The role of dipeptidyl peptidase IV in the cleavage of glucagon family peptides: in vivo metabolism of pituitary adenylate cyclase activating polypeptide-(1–38). J Biol Chem. 2003;278(25):22418–23.
   PubMed Web of Science ®Google Scholar
• Birk S, Sitarz JT, Petersen KA, Oturai PS, Kruuse C, Fahrenkrug J, et al.. The effect of intravenous PACAP38 on cerebral hemodynamics in healthy volunteers. Regul Pept. 2007;140(3):185–91.
   PubMedGoogle Scholar
• Yun HJ, Yoon JH, Lee JK, Noh KT, Yoon KW, Oh HJ, et al.. Daxx mediates activation-induced cell death in microglia by triggering MST1 signalling. EMBO J. 2011;30(12):2465–76.
   PubMed Web of Science ®Google Scholar
• Taylor DL, Pirianov G, Holland S, McGinnity CJ, Norman AL, Reali C, et al.. Attenuation of proliferation in oligodendrocyte precursor cells by activated microglia. J Neurosci Res. 2010;88(8):1632–44.
   PubMed Web of Science ®Google Scholar
• Cao JJ, Li KS, Shen YQ. Activated immune cells in Parkinson’s disease. J Neuroimmune Pharmacol. 2011;6:323–9.
   PubMed Web of Science ®Google Scholar
• Delgado M, Abad C, Martinez C, Juarranz MG, Leceta J, Ganea D, et al.. PACAP in immunity and inflammation. Ann NY Acad Sci. 2003;992:141–57.
   PubMed Web of Science ®Google Scholar
• Ganea D, Delgado M. Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activating polypeptide (PACAP) as modulators of both innate and adaptive immunity. Crit Rev Oral Biol Med. 2002;13(3):229–37.
   PubMedGoogle Scholar
• Li M, Khan AM, Maderdrut JL, Simon EE, Batuman V. The effect of PACAP38 on MyD88-mediated signal transduction in ischemia-/hypoxia-induced acute kidney injury. Am J Nephrol. 2010;32(6):522–32.
   PubMed Web of Science ®Google Scholar
• Smith HS. Activated microglia in nociception. Pain Physician. 2010;13(3):295–304.
   PubMed Web of Science ®Google Scholar
• Ben Mkaddem S, Pedruzzi E, Werts C, Coant N, Bens M, Cluzeaud F, et al.. Heat shock protein gp96 and NAD(P)H oxidase 4 play key roles in Toll-like receptor 4-activated apoptosis during renal ischemia/reperfusion injury. Cell Death Differ. 2010;17:1474–85.
   PubMed Web of Science ®Google Scholar
• Lehnardt SL, Massillon P, Follett FE, Jensen FE, Ratan R, Rosenberg PA, et al.. Activation of innate immunity in the CNS triggers neurodegeneration through a Toll-like receptor 4-dependent pathway. Proc Natl Acad Sci USA. 2003;100:8514.–9.
   PubMed Web of Science ®Google Scholar
• Tang SC, Arumugam TV, Xu X, Cheng A, Mughal MR, Jo DG, et al.. Pivotal role for neuronal Toll-like receptors in ischemic brain injury and functional deficits. Proc Natl Acad Sci USA. 2007;104(34):13798–803.
   PubMed Web of Science ®Google Scholar
• Ock J, Jeong J, Choi WS, Lee WH, Kim SH, Kim IK, et al.. Regulation of Toll-like receptor 4 expression and its signaling by hypoxia in cultured microglia. J Neurosci Res. 2007;85(9):1989–95.
   PubMed Web of Science ®Google Scholar
• Li M, Khan AM, Maderdrut JL, Simon EE, Batuman V. The effect of PACAP38 on MyD88-Mediated signal transduction in ischemia-/hypoxia-induced acute kidney injury. Am J Nephrol. 2010;32(6):522–32.
   PubMed Web of Science ®Google Scholar
• Hayden MS, Ghosh S. Shared principles in NF-kappaB signaling. Cell. 2008;132(3):344–62.
   PubMed Web of Science ®Google Scholar
• Vallabhapurapu S, Karin M. Regulation and function of NF-kappaB transcription factors in the immune system. Ann Rev Immunol. 2009;27:693–733.
   PubMed Web of Science ®Google Scholar
• Solt LA, May MJ. The IkappaB kinase complex: master regulator of NF-kappaB signaling. Immunol Res. 2009;42(1–3):3–18.
   Web of Science ®Google Scholar
• Jeon J, Park KA, Lee H, Shin S, Zhang T, Won M, et al.. Water extract of Cynanchi atrati Radix regulates inflammation and apoptotic cell death through suppression of IKK-mediated NF-kappaB signaling. J Ethnopharmacol. 2011;137:626–34.
   PubMed Web of Science ®Google Scholar
• Jiang W, Fu F, Tian J, Zhu H, Hou J. Curculigoside A attenuates experimental cerebral ischemia injury in vitro and vivo. Neuroscience. 2011;192:572–9.
   PubMed Web of Science ®Google Scholar
• Wang F, Li H, Shi H, Sun B. Pro-apoptotic role of nuclear factor-kappaB in adriamycin-induced acute myocardial injury in rats. Mol Med Report. 2012;5(2):400–4.
   PubMed Web of Science ®Google Scholar
• Wang H, Cho CH. Effect of NF-kappaB signaling on apoptosis in chronic inflammation-associated carcinogenesis. Curr Cancer Drug Targets. 2010;10(6):593–9.
   PubMed Web of Science ®Google Scholar
• Yang YF, Chen Z, Hu SL, Hu J, Li B, Li JT, et al.. Interleukin-1 receptor associated kinases-1/4 inhibition protects against acute hypoxia/ischemia-induced neuronal injury in vivo and in vitro. Neuroscience. 2011;196:25-34.
   PubMed Web of Science ®Google Scholar
• Chu W, Li X, Li C, Wan L, Shi H, Song X, et al.. TGFBR3, a potential negative regulator of TGF-beta signaling, protects cardiac fibroblasts from hypoxia-induced apoptosis. J Cell Physiol. 2011;226(10):2586–94.
   PubMed Web of Science ®Google Scholar
• Sawada M, Kondo N, Suzumura A, Marunouchi T. Production of tumornecrosis factor-alpha by microglia and astrocytes in culture. Brain Res. 1989;491(2):394–7.
   PubMed Web of Science ®Google Scholar
• Sriram K, Matheson JM, Benkovic SA, Miller DB, Luster MI, O’Callaghan JP. Mice deficient in TNF receptors are protected against dopaminergic neurotoxicity: implications for Parkinson’s disease. FASEB J. 2002;16(11):1474–6.
   PubMed Web of Science ®Google Scholar
• Cheong MH, Lee SR, Yoo HS, Jeong JW, Kim GY, Kim WJ, et al.. Anti-inflammatory effects of Polygala tenuifolia root through inhibition of NF-kappaB activation in lipopolysaccharide-induced BV2 microglial cells. J Ethnopharmacol. 2011;137(3):1402–8.
   PubMed Web of Science ®Google Scholar